Clinical characteristics and significance of SMAD4 alteration in colorectal cancer

被引：0
|
作者：
Shimada, Yoshifumi [1 ]
Tajima, Yosuke [1 ]
Nagahashi, Masayuki [1 ]
Ichikawa, Hiroshi [1 ]
Kameyama, Hitoshi [1 ]
Wakai, Toshifumi [1 ]
机构：
[1] Niigata Univ, Grad Sch Med Dent Sci, Dig Gen Surg, Niigata, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J-3023
引用
收藏
页码：1158 / 1158
页数：1
相关论文
共 50 条
  • [21] Exploring the molecular mechanisms and therapeutic potential of SMAD4 in colorectal cancer
    Shan, Hui
    Tian, Guangyu
    Zhang, Yeqing
    Qiu, Zhiyuan
    CANCER BIOLOGY & THERAPY, 2024, 25 (01)
  • [22] Statins Reduce the Risk on Colorectal Cancer in Relation to SMAD4 Expression
    Jacobs, Rutger J.
    Kodach, Liudmila L.
    Weil, Nikki L.
    Voorneveld, Philip W.
    Casparie, Mariel
    Herings, Ron M.
    Morreau, Hans
    van den Brink, Gijs R.
    Hommes, Daniel W.
    Hardwick, James C.
    GASTROENTEROLOGY, 2011, 140 (05) : S104 - S104
  • [23] SMAD4 levels and response to 5-fluorouracil in colorectal cancer
    Alhopuro, P
    Alazzouzi, H
    Sammalkorpi, H
    Dávalos, V
    Salovaara, R
    Hemminki, A
    Järvinen, H
    Mecklin, JP
    Schwartz, S
    Aaltonen, LA
    Arango, D
    CLINICAL CANCER RESEARCH, 2005, 11 (17) : 6311 - 6316
  • [24] Smad4 acts as tumor suppressor by antagonizing lymphangiogenesis in colorectal cancer
    Liu, Yanqing
    Sheng, Jizhang
    Dai, Dianlu
    Liu, Tong
    Qi, Feng
    PATHOLOGY RESEARCH AND PRACTICE, 2015, 211 (04) : 286 - 292
  • [25] Clinical significance of SMAD4 expression in resectable pancreatic cancer: correlation with tumor progression and recurrence pattern
    Yamada, Suguru
    Fujii, Tsutomu
    Kanda, Mitsuro
    Sugimoto, Hiroyuki
    Nomoto, Shuji
    Kodera, Yasuhiro
    CANCER RESEARCH, 2014, 74 (19)
  • [26] Profiling Activins and Follistatin in Colorectal Cancer According to Clinical Stage, Tumour Sidedness and Smad4 Status
    Refaat, Bassem
    Zekri, Jamal
    Aslam, Akhmed
    Ahmad, Jawwad
    Baghdadi, Mohammed A.
    Meliti, Abdelrazak
    Idris, Shakir
    Sultan, Sufian
    Alardati, Hosam
    Saimeh, Haitham Akram
    Alsaegh, Aiman
    Alhadrami, Mai
    Hamid, Tahira
    Naeem, Mohammed E.
    Elsamany, Shereef Ahmed
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [27] The Smad4/PTEN Expression Pattern Predicts Clinical Outcomes in Colorectal Adenocarcinoma
    Chung, Yumin
    Wi, Young Chan
    Kim, Yeseul
    Bang, Seong Sik
    Yang, Jung-Ho
    Jang, Kiseok
    Min, Kyueng-Whan
    Paik, Seung Sam
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2018, 52 (01) : 37 - 44
  • [28] SMAD4 loss is associated with poor prognosis in Middle Eastern colorectal cancer
    Ahmed, Maqbool
    Siraj, Abdul K.
    Masoodi, Tariq
    Bu, Rong
    Al-Dayel, Fouad
    Al-Kuraya, Khawla S.
    CANCER RESEARCH, 2017, 77
  • [29] A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer
    Voorneveld, Philip W.
    Jacobs, Rutger J.
    Kodach, Liudmila L.
    Hardwick, James C. H.
    TRANSLATIONAL ONCOLOGY, 2015, 8 (01) : 18 - 24
  • [30] Smad4 re-expression increases the sensitivity to parthenolide in colorectal cancer
    Li, Xuemei
    Yang, Huike
    Ke, Jia
    Liu, Baoquan
    Lv, Xiaohong
    Li, Xinlei
    Zhang, Yafang
    ONCOLOGY REPORTS, 2017, 38 (04) : 2317 - 2324
12345